Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Depressive symptoms, bidirectionally associated with insomnia, are common comorbidity among patients with schizophrenia. The current literature lacks conclusive evidence about the mediating role of either positive or negative symptoms in the relationship between insomnia and depressive symptoms.

Aim/question: This study aimed to examine the mediating role of psychotic symptoms on the relationship between insomnia and depression in a sample of patients with schizophrenia.

Methods: A cross-sectional, mediational design was used in this cross-sectional study, using a convenience sampling method to recruit 279 patients with schizophrenia.

Results: Insomnia total score ( = 0.351, p < 0.001), work status ( = 3.053, p < 0.001), living arrangement ( = -2.071, p = 0.019), number of previous suicide attempts ( = 1.087, p < 0.001) and medication adherence ( = -1.456, p = 0.031) explained 41.9% of the variability in depression total score (F = 41.14, p < 0.001). Negative psychotic symptoms positively (partially) mediated the relationship between insomnia and depression (p < 0.001).

Discussion: The indirect effect for the negative psychotic symptom total score was significant and positive. This finding implies that, on average, higher insomnia total scores increase negative psychotic symptom total scores, which then increase depression scores.

Implications For Practice: The study highlights the significance of early detection and management of insomnia by integrating sleep assessments into standard mental health care to mitigate the negative impact of insomnia on both psychotic and depressive symptoms. Furthermore, this proactive approach may help mental health nurses improve patients' long-term outcomes by addressing these comorbidities before they escalate.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jpm.13175DOI Listing

Publication Analysis

Top Keywords

relationship insomnia
12
insomnia depressive
8
depressive symptoms
8
sample patients
8
patients schizophrenia
8
psychotic symptoms
8
mediating role
8
symptoms relationship
8
symptoms
5
symptoms sample
4

Similar Publications

Hypocretin: a promising target for the regulation of homeostasis.

Front Neurosci

August 2025

Beijing Life Science Academy, Beijing, China.

Hypocretin, also known as orexin, is a hypothalamic neuropeptide that regulates essential physiological processes including arousal, energy metabolism, feeding behavior, and emotional states. Through widespread projections and two G-protein-coupled receptors-HCRT-1R and HCRT-2R-the hypocretin system exerts diverse modulatory effects across the central nervous system. The role of hypocretin in maintaining wakefulness is well established, particularly in narcolepsy type 1 (NT1), where loss of hypocretin neurons leads to excessive daytime sleepiness and cataplexy.

View Article and Find Full Text PDF

Introduction: Anxiety, depression, and insomnia are common among older patients with tuberculosis (TB), yet their associations with inflammatory responses and drug-induced liver injury (DILI) remain insufficiently explored. This study aimed to identify distinct inflammation-DILI phenotypes in older TB patients and examine differences in anxiety, depression, and insomnia across subgroups.

Methods: In this cross-sectional study, 251 older TB patients were evaluated.

View Article and Find Full Text PDF

Hyperhomocysteinemia in chronic schizophrenia: prevalence, clinical correlates, and paradoxical associations with symptom severity.

Eur Arch Psychiatry Clin Neurosci

September 2025

Tianjin Anding Hospital, Institute of Mental Health, Psychiatric Medical Center of Tianjin University, Mental Health Center of Tianjin Medical University, 13 Liulin Road, Tianjin, 300222, China.

Background: Elevated homocysteine levels, known as hyperhomocysteinemia (HHcy), have been implicated in the pathophysiology of schizophrenia. Most prior studies focused on first-episode or acute-phase schizophrenia patients, leaving the prevalence, determinants, and clinical correlates of HHcy in chronic schizophrenia understudied. This study aims to investigate the prevalence and determinants of HHcy in patients with chronic schizophrenia, as well as its clinical correlates.

View Article and Find Full Text PDF

Introduction: Co-morbid insomnia and sleep apnea (COMISA) has been linked to poorer health outcomes and increased all-cause mortality compared with either insomnia or obstructive sleep apnea (OSA) alone.

Materials And Methods: We investigated the relationship between COMISA and uncontrolled hypertension in the Swedish CardioPulmonary BioImage Study (SCAPIS). A cross-sectional analysis including participants from the SCAPIS Gothenburg cohort (n=3832, 46% males, age 57.

View Article and Find Full Text PDF

Background: The association observed between mental stress and metabolic syndrome (MetS) has varied across studies and may be confounded by physical activity (PA) and fitness status.

Method: This study included a military cohort of 2,854 participants in Taiwan who were not taking any medications and were free of baseline MetS. The Brief Symptoms Rating Scale (BSRS-5) includes five domains-depression, anxiety, hostility, insomnia, and interpersonal sensitivity-measured on a five-point Likert-type scale ranging from 0 to 4, with a maximum score of 20.

View Article and Find Full Text PDF